Uganda researchers are excited at the new results of a trial, which showed that an injectable ARV was highly effective in preventing HIV for two months. On Tuesday, ViiV Healthcare, the US National ...

Uganda has started recruiting women for trials of a long-lasting injectable antiretroviral drug for Pre-Exposure Prophylaxis. This is part of a large scale trial that will also be conducted in six ...

Botswana has approved the use of injectable anti-retroviral (ARV) drugs to improve adherence to HIV treatment. Minister of Health Edwin Dikoloti says the injections, given every two months, are more ...

Ugandan HIV activists Barbara Kemigisa shows Antiretroviral (ARV) packagings and tablets in an art design encouraging people infected with HIV to use the ARVs and fight against stigmatisation during ...

Arguably the most eagerly awaited study findings in HIV are from research on an antiretroviral (ARV) injection that may prevent HIV infection in women. If it works, the option of getting an injection ...

• Beatrice Nyagol, a research officer at Impact Research, a local non-profit based in Kisumu, said a current study is getting long-term injectable treatment for adolescents. •The drug comes as a ...

Ugandan HIV activists Barbara Kemigisa shows Antiretroviral (ARV) packagings and tablets in an art design encouraging people infected with HIV to use the ARVs and fight against stigmatisation during ...

Uganda has started recruiting women for trials of a long-lasting injectable antiretroviral drug for Pre-Exposure Prophylaxis. This is part of a large scale trial that will also be conducted in six ...

• Beatrice Nyagol, a research officer at Impact Research, a local non-profit based in Kisumu, said a current study is getting long-term injectable treatment for adolescents. •The drug comes as a ...